Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dorval

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Presse Medicale (Paris, France : 1983)|August 3, 2000
[Standards, options, and recommendations for the management of patients with skin melanoma. National Federation of Centers for the Fight against Cancer]S Négrier, B Fervers, C Bailly, et al.
British Journal of Cancer|May 18, 2001
Cutaneous melanomaS Négrier, B Fervers, C Bailly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancerM Spielmann, T Dorval, F Turpin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapyS Leyvraz, V Spataro, J Bauer, et al.
Bulletin Du Cancer|March 8, 2000
[Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer]S Négrier, B Fervers, C Bailly, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 1998
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapyR J Salmon, C Levy, C Plancher, et al.
Bulletin Du Cancer|January 1, 1989
[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials]M Jouve, T Palangie, L Belli, et al.
British Journal of Cancer|May 1, 1994
Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patientsE Tartour, T Dorval, V Mosseri, et al.
Gynecologic Oncology|August 1, 1997
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinomaJ Y Pierga, V Diéras, P Beuzeboc, et al.
Bulletin Du Cancer|January 1, 1986
[Phase II trial of an ambulatory treatment with 5-fluorouracil administered by continuous perfusion combined with vindesine and cyclophosphamide]T Palangie, G Bastian, C Demarcq, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Presse Medicale (Paris, France : 1983)|August 3, 2000
[Standards, options, and recommendations for the management of patients with skin melanoma. National Federation of Centers for the Fight against Cancer]S Négrier, B Fervers, C Bailly, et al.
British Journal of Cancer|May 18, 2001
Cutaneous melanomaS Négrier, B Fervers, C Bailly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancerM Spielmann, T Dorval, F Turpin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapyS Leyvraz, V Spataro, J Bauer, et al.
Bulletin Du Cancer|March 8, 2000
[Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer]S Négrier, B Fervers, C Bailly, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 1998
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapyR J Salmon, C Levy, C Plancher, et al.
Bulletin Du Cancer|January 1, 1989
[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials]M Jouve, T Palangie, L Belli, et al.
British Journal of Cancer|May 1, 1994
Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patientsE Tartour, T Dorval, V Mosseri, et al.
Gynecologic Oncology|August 1, 1997
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinomaJ Y Pierga, V Diéras, P Beuzeboc, et al.
Bulletin Du Cancer|January 1, 1986
[Phase II trial of an ambulatory treatment with 5-fluorouracil administered by continuous perfusion combined with vindesine and cyclophosphamide]T Palangie, G Bastian, C Demarcq, et al.
Pageof 11